Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 18,451 shares at $6.24 ($115K) on 2024-06-27, disclosed to the SEC on 2024-07-01.
Scheduled sale ($115k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.24 | 9,078 | $57K | 49.2% |
| 2 | $6.24 | 9,078 | $57K | 49.2% |
| 3 | $6.26 | 295 | $2K | 1.6% |
| Total | $6.24 avg | 18,451 | $115K | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $350K | — | Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |